T HE THALASSEMIAS
In order to confirm reproducibility, to apply more stringent inhibition of proteolysis, and to utilize newer methods of quantifying polypeptide composition, most patients were restudied at Stanford.
Heparinized whole blood samples arrived at Stanford within 36 hours after being drawn. Upon arrival they were washed, and the buffy coat was removed.
The hematocrit value was brought to 50% with isotonic saline, to which 2 mmol/L diisopropyl fluorophosphate (DFP) and 10 g/mL of pepstatin A and of leupeptin were added to prevent proteolysis. The thalassemia intermedia patients rarely required blood transfusions, and none had been transfused 2 to 3 months prior to study. The thalassemia major samples were obtained just prior to the next transfusion, typically 4 weeks after the last transfusion.
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